Evidence map›Paper›PMID 20437210›Full record

ReviewMolecular neurobiology2010

Membrane biophysics and mechanics in Alzheimer's disease.

Xiaoguang Yang, Sholpan Askarova, James C-M Lee

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. MERCs. The Novel Assistant to Neurotransmission?Frontiers in neuroscience · 2020
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xiaoguang YangDepartment of Biological Engineering, University of Missouri, 240 Agricultural Engineering Building, Columbia, MO 65211, USA.
Sholpan Askarova
James C-M Lee
University of Missouri · US

Funding

NIA NIH HHS 1P01AG18357NIA NIH HHS 1R21AG032579NINDS NIH HHS 1R21NS052385
6 · The paper itself

Abstract

Alzheimer's disease is a chronic neurodegenerative disorder characterized by neuronal loss, cerebrovascular inflammation, and accumulation of senile plaques in the brain parenchyma and cerebral blood vessels. Amyloid-beta peptide (Abeta), a major component of senile plaques, has been shown to exert multiple toxic effects to neurons, astrocytes, glial cells, and brain endothelium. Oligomeric Abeta can disturb the structure and function of cell membranes and alter membrane mechanical properties, such as membrane fluidity and molecular order. Much of these effects are attributed to their capability to trigger oxidative stress and inflammation. In this review, we discuss the effects of Abeta on neuronal cells, astrocytes, and cerebral endothelial cells with special emphasis on cell membrane properties and cell functions.

Indexed as

Alzheimer DiseaseCell MembraneAmyloid beta-PeptidesAstrocytesCalciumCerebrovascular CirculationCholesterolEndothelial CellsMitochondriaNeuronsOxidative StressPhospholipases A2Amyloid beta-PeptidesCalciumCholesterolPhospholipases A2

Identifiers

PMID20437210
OpenAlexW2122689772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.